Id
Protein
PTM type
Site
Species
Disease
Celline
Drug
Regulatory
Score
Ref.
acc00051 "Actin, cytoplasmic 2" oxidation Met49 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00052 "Actin, cytoplasmic 2, N-terminally processed" oxidation Met49 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00053 "Actin, alpha cardiac muscle 1" oxidation Met48 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00054 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met49 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00055 "Actin, alpha skeletal muscle" oxidation Met48 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00056 "Actin, alpha cardiac muscle 1" oxidation Met84 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00057 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met84 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00058 "Actin, alpha skeletal muscle" oxidation Met83 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00059 "Actin, alpha skeletal muscle, intermediate form" oxidation Met84 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00060 Elongation factor 1-alpha 1 oxidation Met404 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00061 Putative elongation factor 1-alpha-like 3 oxidation Met404 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00062 Tubulin alpha-1B chain oxidation Met377 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00063 Detyrosinated tubulin alpha-1B chain oxidation Met377 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00064 Tubulin alpha-4A chain oxidation Met377 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00065 Tubulin alpha-1B chain oxidation Met302 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00066 Detyrosinated tubulin alpha-1B chain oxidation Met302 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00067 Neuroblast differentiation-associated protein AHNAK oxidation Met820 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00068 Calponin-3 oxidation Met219 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00069 Histone H3.2 oxidation Met91 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00070 ERO1-like protein alpha oxidation Met342 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00071 Alpha-actinin-4 oxidation Met729 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00072 Alpha-actinin-1 oxidation Met710 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00073 Alpha-actinin-2 oxidation Met717 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00074 Barrier-to-autointegration factor oxidation Met15 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00075 "Keratin, type I cytoskeletal 18" oxidation Met402 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00076 Tubulin beta chain oxidation Met233 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00077 Tubulin beta-4B chain oxidation Met233 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00078 Tubulin beta-4A chain oxidation Met233 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00079 Heat shock protein HSP 90-alpha oxidation Met521 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00080 Heat shock protein HSP 90-beta oxidation Met363 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00081 Small ribosomal subunit protein uS2 oxidation Met34 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00082 "60 kDa heat shock protein, mitochondrial" oxidation Met145 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00083 Proliferating cell nuclear antigen oxidation Met119 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00084 Glucosidase 2 subunit beta oxidation Met490 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00085 Pyruvate kinase PKM oxidation Met360 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00086 Pyruvate kinase PKM oxidation Met239 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00087 Heterogeneous nuclear ribonucleoprotein L oxidation Met567 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00088 Elongation factor 1-beta oxidation Met155 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00089 Large ribosomal subunit protein uL16 oxidation Met52 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00090 Myosin-9 oxidation Met1190 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00091 Myosin-9 oxidation Met86 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00092 Myosin-10 oxidation Met90 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00093 Transgelin-2 oxidation Met189 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00094 Transgelin-3 oxidation Met189 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00095 Transaldolase oxidation Met303 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00096 Eukaryotic initiation factor 4A-III oxidation Met7 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00097 Myosin light polypeptide 6 oxidation Met73 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00098 Small ribosomal subunit protein eS6 oxidation Met32 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00099 Peptidyl-prolyl cis-trans isomerase A oxidation Met1 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00100 Elongation factor 1-alpha 1 oxidation Met410 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929